Hematology - European Medical Journal

Continue

Hematology

Filter
9 Mins
8 Aug 2017

Management of Adult Patients with Myelodysplastic Syndromes

The myelodysplastic syndromes form a heterogeneous group of clonal disorders with an increasing incidence in the elderly population and an emerging…
7 Mins
8 Aug 2017

Different Therapeutic Interventions and Mechanisms of Action of Antisickling Agents Currently in Use in Sickle Cell Disease Management

Sickle cell disease is a genetic disorder caused by sickle haemoglobin. In many forms of the disease, the red blood cells can change shape upon…
11 Mins
28 Jul 2017

The Pivotal Role of Proteasome Inhibition in Myeloma Treatment

Prof Munshi opened the presentation with a brief video highlighting the interaction of myeloma cells with the bone microenvironment…
11 Mins
1 Jun 2017

Extension of 2016 World Health Organization (WHO) Classification into a New Set of Clinical, Laboratory, Molecular, and Pathological Criteria for the Diagnosis of Myeloproliferative Neoplasms: From Dameshek to Vainchenker, Green, and Kralovics

Improved Clinical, Laboratory, Molecular, and Pathological (CLMP) 2017 criteria for myeloproliferative neoplasms (MPN) define the JAK2V617F trilinear…
7 Mins
2 Mar 2017

Hide and Seek: The Game Between Chronic Lymphocytic Leukaemia Cells and B Cell Receptor Signalling Inhibitors

The emergence of B cell receptor (BCR) kinase inhibitors has recently changed the treatment landscape in chronic lymphocytic leukaemia (CLL). The…
13 Dec 2016

Non-Transfusion-Dependent Thalassaemia: A Panoramic Survey from Pathophysiology to Treatment

Non-transfusion-dependent thalassaemia (NTDT) is a rather broad term that encompasses a group of thalassaemia syndromes, most commonly β-thalassaemia…
8 Mins
28 Jul 2016

Biosimilars: Shaping the Future of Haematology

Prof Robin Foà opened the symposium by highlighting how improving healthcare and an ageing population are increasing the burden on healthcare resources…
9 Mins
28 Jul 2016

Advances in the Treatment of Non-Hodgkin’s Lymphoma: Exploring New Frontiers

A recent symposium at the European Hematology Association (EHA) congress, chaired by Prof Eva Kimby, explored the changing paradigms in the treatment of…